Form 4 for CGEM Cullinan Therapeutics, Inc.
Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-08 · accession 0000899243-21-035415 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-09 | 2021-09-08 | CGEM | Baeuerle Patrick | See Remarks | M - OptEx | $4.30 | +11.0K | 11.0K | New | +$47.3K |
| D | 2021-09-09 | 2021-09-08 | CGEM | Baeuerle Patrick | See Remarks | S - Sale+OE | $28.45 | -11.0K | 0 | -100% | -$312.9K |
| D | 2021-09-09 | 2021-09-08 | CGEM | Baeuerle Patrick | See Remarks | M - OptEx | $0.00 | -11.0K | 240.1K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-08 | M | A | 11,000 | $4.30 | 11,000 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-08 | S | D | 11,000 | $28.45 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-08 | M | D | 11,000 | $0.00 | 240,114 | D | $4.30 · — to 2030-10-28 | 11,000 Common Stock | (F3) 25% of the shares vested on September 1, 2019, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. |